[神经内分泌瘤治疗的最新进展]
Barbara Kiesewetter-Wiederkehr1, Philipp Melhorn2, Christian Scheuba3
1Klinische Abteilung für Onkologie, Universitätsklinik für Innere Medizin I, Medizinische Universität Wien, Waehringer Guertel 18-20, 1090, Wien, Österreich. barbara.kiesewetter@meduniwien.ac.at.
Radiologie (Heidelberg, Germany)
|April 22, 2024
概括
对神经内分泌瘤 (NET) 有有效的治疗方法,从手术到先进的药物治疗,如索马托斯塔丁类似物和受体放射性核酸治疗 (PRRT). 跨学科的管理是最佳患者结果的关键.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 内分泌学 在内分泌学.
背景情况:
- 神经内分泌瘤 (NET) 是一种罕见的,异质的恶性瘤,需要复杂的治疗.
- 尽管异质,目前的全身疗法为许多NET患者提供了有利的预后.
研究的目的:
- 为神经内分泌瘤 (NET) 提供当前治疗策略的全面概述.
- 针对主要解剖部位的NET治疗.
主要方法:
- 审查目前关于NET处理的欧洲指导方针.
- 包括有关NET治疗方法的相关文献.
主要成果:
- 治疗范围包括局部NET (胃,十二指肠,尾,直肠) 的内镜/手术切除.
- 治愈切除对于早期NET (胰腺,小肠,肺) 非常重要.
- 转移性NET的先进疗法包括局部治疗 (栓塞),体静止素类型,mTOR抑制剂,氨酸激酶抑制剂,受体放射性核酸治疗 (PRRT) 和化疗.
结论:
- 对于神经内分泌瘤,存在广泛的有效疗法.
- 跨学科的合作对于及时和适当的患者特定治疗选择至关重要.
更多相关视频
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:27Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
160
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
160